14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 74 days ( -12.90 % )
Last Price $1.07 0 %
High/ Low $1.07 - $1.07 0%
Chg 7 Days N/A $1.07 $1.07
Chg 30 Days N/A $1.07 $1.07
Chg 12 mos 20.89 % $0.89 $1.07
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 37.22 % Width: 73.21 %
Pred. range - 3 mos $1.07 - $1.07 0 % - 0 %
Pred. range - 12 mos $1.09 - $1.88 1.61 % - 76.00 %
Short MA avg 3 mos Sell Sep 13, 2023 - 59 days
Long MA avg 3 mos Sell Oct 24, 2023 - 31 days
Short/Long MA avg 3 mos Sell Oct 24, 2023 - 31 days
Short MA avg 12 mos Sell Oct 04, 2023 - 45 days
Long MA avg 12 mos Sell May 24, 2023 - 135 days
Short/Long MA avg 12 mos Buy Jun 07, 2023 - 126 days
Pivot Short Sell Dec 05, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Surface Oncology Inc.

Surface Oncology. Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine... SURF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT